In addition, loss of Kindlin-1 in patients with Kindler Syndrome (KS) promotes tumorigenesis, with KS patients having a propensity to develop highly aggressive cutaneous squamous cell carcinoma (cSCC) [12–14]. Here, FERMT1 is linked to Kindler syndrome.